Transfeminine Hormone Therapy.

Oksana Hamidi, Caroline J Davidge-Pitts

Journal: Endocrinology and metabolism clinics of North America 2020;48(2):341-355

PMID: 31027544

Full Text on Elsevier Science View on PubMed

Abstract

Transgender women often seek hormone therapy to attain feminine physical features congruent with their gender identity. The aim of feminizing hormone therapy (FHT) is to provide suppression of endogenous testosterone and to maintain estradiol levels within the normal female range. Overall, FHT is safe if provided under supervision of an experienced health care provider and has been shown to improve quality of life. Data on care of transgender women are scarce and high-quality evidence-based recommendations are lacking. This article aims to review the published literature on FHT and provide guidance to clinicians caring for transgender women.

Address: Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, 2001 Inwood Road, Dallas, TX 75235, USA.; Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55902, USA. Electronic address: [email protected].

DOI: 10.1016/j.ecl.2019.02.001

Link outs

Free resources

Medical:

https://clinicaltrials.gov/search?term=AREA%5BRefe...

Subscription / membership required

Full Text Sources:

MeSH Terms: Androgen Antagonists, Estrogen Replacement Therapy, Gender Dysphoria, Gonadotropin-Releasing Hormone, Humans, Transsexualism